<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>BioScreening.net &#187; Proteomics</title>
	<atom:link href="http://www.bioscreening.net/category/news/proteomics/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.bioscreening.net</link>
	<description>BioScreening news and events</description>
	<lastBuildDate>Thu, 29 Dec 2011 08:21:20 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
		<item>
		<title>KINAXOâ€™s Cellular Target ProfilingÂ® reveals mTOR as a new target of Celebrex</title>
		<link>http://www.bioscreening.net/2009/05/10/kinaxo%e2%80%99s-cellular-target-profiling%c2%ae-reveals-mtor-as-a-new-target-of-celebrex/</link>
		<comments>http://www.bioscreening.net/2009/05/10/kinaxo%e2%80%99s-cellular-target-profiling%c2%ae-reveals-mtor-as-a-new-target-of-celebrex/#comments</comments>
		<pubDate>Mon, 11 May 2009 00:46:24 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Proteomics]]></category>
		<category><![CDATA[Targeted Libraries]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2009/05/10/kinaxo%e2%80%99s-cellular-target-profiling%c2%ae-reveals-mtor-as-a-new-target-of-celebrex/</guid>
		<description><![CDATA[Martinsried, Germany, April 29, 2009 / b3c newswire /Â - Kinaxo Biotechnologies GmbH has successfully applied its Cellular Target ProfilingÂ® technology to identify the protein kinase mTOR as a new cellular target of celecoxib (CelebrexÂ®, Pfizer). Celecoxib is a non-steroidal, anti-inflammatory Cox-2 inhibitor approved for the treatment of osteoarthritis, rheumatoid arthritis and acute pain. In addition, [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2009/05/10/kinaxo%e2%80%99s-cellular-target-profiling%c2%ae-reveals-mtor-as-a-new-target-of-celebrex/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Molecular Fingerprints Point The Way To Earlier Cancer Diagnosis And More Targeted Treatment</title>
		<link>http://www.bioscreening.net/2009/03/27/molecular-fingerprints-point-the-way-to-earlier-cancer-diagnosis-and-more-targeted-treatment/</link>
		<comments>http://www.bioscreening.net/2009/03/27/molecular-fingerprints-point-the-way-to-earlier-cancer-diagnosis-and-more-targeted-treatment/#comments</comments>
		<pubDate>Sat, 28 Mar 2009 01:52:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[ChemInformatics]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Proteomics]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2009/03/27/molecular-fingerprints-point-the-way-to-earlier-cancer-diagnosis-and-more-targeted-treatment/</guid>
		<description><![CDATA[ScienceDaily (Mar. 27, 2009) â€” Metabolites are molecular fingerprints of what your cells are up to and Dr. Arun Sreekumar wants to know the impression made by cancer. You&#8217;ve likely heard about metabolites; your physician probably screens for some known ones such as triglycerides or cholesterol at your annual physical. Scientists suspect we have about [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2009/03/27/molecular-fingerprints-point-the-way-to-earlier-cancer-diagnosis-and-more-targeted-treatment/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AnaSpec Introduces New SensoLyteTM MMP ELISA Kits</title>
		<link>http://www.bioscreening.net/2008/10/23/anaspec-introduces-new-sensolytetm-mmp-elisa-kits/</link>
		<comments>http://www.bioscreening.net/2008/10/23/anaspec-introduces-new-sensolytetm-mmp-elisa-kits/#comments</comments>
		<pubDate>Thu, 23 Oct 2008 18:46:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[New Products]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Peptide Research]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Proteomics]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/10/23/anaspec-introduces-new-sensolytetm-mmp-elisa-kits/</guid>
		<description><![CDATA[San Jose, CA October 16, 2008 Matrix metalloproteinases (MMPs) belong to a family of secreted or membrane-associated zinc endopeptidases involved in both normal and diseased tissue remodeling. They are capable of degrading all kinds of extracellular matrix (ECM) proteins, but also can process a number of bioactive molecules. MMPs are key players in normal and [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/10/23/anaspec-introduces-new-sensolytetm-mmp-elisa-kits/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Thermo Fisher Scientific Holds European Proteomics Seminar Series on Protein Quantitation</title>
		<link>http://www.bioscreening.net/2008/10/15/thermo-fisher-scientific-holds-european-proteomics-seminar-series-on-protein-quantitation/</link>
		<comments>http://www.bioscreening.net/2008/10/15/thermo-fisher-scientific-holds-european-proteomics-seminar-series-on-protein-quantitation/#comments</comments>
		<pubDate>Wed, 15 Oct 2008 14:51:42 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Europe]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Proteomics]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/10/15/thermo-fisher-scientific-holds-european-proteomics-seminar-series-on-protein-quantitation/</guid>
		<description><![CDATA[SAN JOSE, Calif. (October 15, 2008) &#8211; Thermo Fisher Scientific Inc., the world leader in serving science, today announced the dates for its 2008 European Proteomics Seminar Series. The series, which takes place throughout October and November, has become an established venue for scientific and technological discussion and the sharing of practical tips. The theme [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/10/15/thermo-fisher-scientific-holds-european-proteomics-seminar-series-on-protein-quantitation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biological Drugs Spurring an Evolution in Injectable Drug Delivery</title>
		<link>http://www.bioscreening.net/2008/01/03/biological-drugs-spurring-an-evolution-in-injectable-drug-delivery/</link>
		<comments>http://www.bioscreening.net/2008/01/03/biological-drugs-spurring-an-evolution-in-injectable-drug-delivery/#comments</comments>
		<pubDate>Thu, 03 Jan 2008 23:48:35 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Equipment & Supplies]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Peptide Research]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Proteomics]]></category>
		<category><![CDATA[Reports]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/01/03/biological-drugs-spurring-an-evolution-in-injectable-drug-delivery/</guid>
		<description><![CDATA[(Amherst, NH) &#8211; The success of recombinant protein drugs such as Enbrel, Remicade, and Herceptin in treating refractory conditions is fueling the search for protein and peptide-based therapeutic agents in oncology, inflammation and a host of other disease classes. Led by the proliferation of antibody-based drug candidates, biological drugs as a class continue to outpace [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/01/03/biological-drugs-spurring-an-evolution-in-injectable-drug-delivery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>7th Annual Protein Kinases Congress 10-12 March 2008 in Crowne Plaza Berlin City Centre, Berlin, Germany</title>
		<link>http://www.bioscreening.net/2007/11/04/7th-annual-protein-kinases-congress-10-12-march-2008-in-crowne-plaza-berlin-city-centre-berlin-germany/</link>
		<comments>http://www.bioscreening.net/2007/11/04/7th-annual-protein-kinases-congress-10-12-march-2008-in-crowne-plaza-berlin-city-centre-berlin-germany/#comments</comments>
		<pubDate>Mon, 05 Nov 2007 01:41:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Proteomics]]></category>
		<category><![CDATA[Targeted Libraries]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/11/04/7th-annual-protein-kinases-congress-10-12-march-2008-in-crowne-plaza-berlin-city-centre-berlin-germany/</guid>
		<description><![CDATA[Innovating kinase inhibitor development is the key to successful clinical development. At Informa Life Sciences 7th Annual Protein Kinases Congress hear the latest thinking and strategies towards creating a selective inhibitor. Learn about new targets, industry trends in structure-based drug design, clinical case-studies and discuss the issue of cardiotoxicity. For more information visit: http://www.iir-events.com/IIR-Conf/page.aspx?id=9547]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/11/04/7th-annual-protein-kinases-congress-10-12-march-2008-in-crowne-plaza-berlin-city-centre-berlin-germany/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PepCon-2008 Shenzhen, China on April 22-24, 2008</title>
		<link>http://www.bioscreening.net/2007/11/04/pepcon-2008-shenzhen-china-on-april-19-21-2008/</link>
		<comments>http://www.bioscreening.net/2007/11/04/pepcon-2008-shenzhen-china-on-april-19-21-2008/#comments</comments>
		<pubDate>Mon, 05 Nov 2007 00:51:30 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[Peptide Research]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Proteomics]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/11/04/pepcon-2008-shenzhen-china-on-april-19-21-2008/</guid>
		<description><![CDATA[Advances in peptide and protein researches are occurring at an ever increasing pace, in a wide range of fields and scientific disciplines. At this exciting time, it is especially important to promote scientific and technological exchange and cooperation at the international level. To establish of a new educational and networking platform for protein and peptide [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/11/04/pepcon-2008-shenzhen-china-on-april-19-21-2008/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog</title>
		<link>http://www.bioscreening.net/2007/10/18/strategic-diagnostics-launches-initial-oncology-targeted-antibody-reagent-catalog/</link>
		<comments>http://www.bioscreening.net/2007/10/18/strategic-diagnostics-launches-initial-oncology-targeted-antibody-reagent-catalog/#comments</comments>
		<pubDate>Thu, 18 Oct 2007 17:11:33 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Proteomics]]></category>
		<category><![CDATA[Reagents]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/10/18/strategic-diagnostics-launches-initial-oncology-targeted-antibody-reagent-catalog/</guid>
		<description><![CDATA[NEWARK, Del., Oct. 2 /PRNewswire-FirstCall/ &#8212; Strategic Diagnostics Inc. &#8212; today announced the launch of a new internet based catalog of antibody reagents in support of oncology-based research and discovery. These high-quality reagents have all been manufactured utilizing SDI&#8217;s proprietary Genomic Antibody Technology(TM) and will carry the SEQer(TM) brand. The catalog is available at http://antibodies.sdix.com [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/10/18/strategic-diagnostics-launches-initial-oncology-targeted-antibody-reagent-catalog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Proteomic profiling to assess genetically modified crop safety</title>
		<link>http://www.bioscreening.net/2006/01/11/proteomic-profiling-to-assess-genetically-modified-crop-safety/</link>
		<comments>http://www.bioscreening.net/2006/01/11/proteomic-profiling-to-assess-genetically-modified-crop-safety/#comments</comments>
		<pubDate>Wed, 11 Jan 2006 13:26:25 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Europe]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Proteomics]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2006/01/11/proteomic-profiling-to-assess-genetically-modified-crop-safety/</guid>
		<description><![CDATA[Wednesday, January 11, 2006 By Sirpa O. KÃƒÂ¤renlampi and Satu J. Lehesranta It is generally accepted that traditional food is safe for the majority of consumers. For the introduction of a new variant or cultivar developed from a traditional crop plant, maximum limits have been set in some cases, e.g., for potato and oilseed rape, [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2006/01/11/proteomic-profiling-to-assess-genetically-modified-crop-safety/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

